In this study, cancer cells can be induced to a Synergistic effect by EZH2i upon genetic ablation of NF-κB, indicating that redundant survival pathway(s)/mechanism(s) of EZH2 can compensate for the loss of NF-κB activity. This evidence concerns the gene EZH2 and cancer.